Why would there be zero investor activity over those 2 months?
I'm sure management are doing everything they can to try and save face and their jobs, although I'm thinking some heads will roll over that miscommunication with the loss of a contract.
This release in feb made out that this year especially H2 FY17 was the company maker. I read somewhere that the director at the time FW said that they didn't have enough supply at the time to expand into India because of the Chinese contracts but now they are no more at the moment maybe they should look towards India and the Middle East.
I'm more interested in Santalis and what they are up to. With one phase 3 trial and four phase 2 trials it has plenty of potential in my eyes. And I'm watching closing how QIN gets the most out of it for shareholders. Possible US Listing.?
http://www.asx.com.au/asxpdf/20170227/pdf/43gbhn180dswsm.pdf
